Latest News
Veklury Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19
23 September 2021 - - US-based Gilead Sciences, Inc. (NASDAQ: GILD) has posted positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of a three-day course of Veklury (remdesivir) f...
CytoDyn Receives Clearance from Brazil's FDA to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)
23 September 2021 - - Brazil's regulatory authority, ANVISA (Agência Nacional de Vigilância Sanitária), has approved the start of an additional Phase 3 CD16 clinical trial of leronlimab, US-based biotechnology company CytoDyn ...
Arcturus Therapeutics Receives Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
23 September 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has completed dosing of 100 subjects for the Phase 1 portion of the ARCT-154 Phase 1/2/3 clinical trial, which consisted ...
EMA to decide on Pfizer's COVID-19 booster shot in early October
23 September 2021 - The European Medicines Agency (EMA), the EU's drug regulator, is expected to decide in early October on the possible use of a booster dose of the Pfizer (NYSE:PFE)/BioNTech (Nasdaq:BNTX) COVID-19 vaccine, Reuters news agency ...
DFC and Citi to provide Gavi with equitable access to COVID-19 vaccines across the world via COVAX Facility
23 September 2021 - American development bank U.S. International Development Finance Corporation (DFC) and Citi Risk Management Solution on Wednesday jointly announced a risk management solution to help Gavi to mitigate risk and overcome financial hu...